These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19421002)

  • 1. LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors.
    Aparicio A; North B; Barske L; Wang X; Bollati V; Weisenberger D; Yoo C; Tannir N; Horne E; Groshen S; Jones P; Yang A; Issa JP
    Epigenetics; 2009 Apr; 4(3):176-84. PubMed ID: 19421002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas.
    Stewart DJ; Issa JP; Kurzrock R; Nunez MI; Jelinek J; Hong D; Oki Y; Guo Z; Gupta S; Wistuba II
    Clin Cancer Res; 2009 Jun; 15(11):3881-8. PubMed ID: 19470736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
    De Smet C; De Backer O; Faraoni I; Lurquin C; Brasseur F; Boon T
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7149-53. PubMed ID: 8692960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells.
    Tsai HC; Li H; Van Neste L; Cai Y; Robert C; Rassool FV; Shin JJ; Harbom KM; Beaty R; Pappou E; Harris J; Yen RW; Ahuja N; Brock MV; Stearns V; Feller-Kopman D; Yarmus LB; Lin YC; Welm AL; Issa JP; Minn I; Matsui W; Jang YY; Sharkis SJ; Baylin SB; Zahnow CA
    Cancer Cell; 2012 Mar; 21(3):430-46. PubMed ID: 22439938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
    Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
    BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypomethylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues.
    Kim KH; Choi JS; Kim IJ; Ku JL; Park JG
    World J Gastroenterol; 2006 Sep; 12(35):5651-7. PubMed ID: 17007017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.
    Samlowski WE; Leachman SA; Wade M; Cassidy P; Porter-Gill P; Busby L; Wheeler R; Boucher K; Fitzpatrick F; Jones DA; Karpf AR
    J Clin Oncol; 2005 Jun; 23(17):3897-905. PubMed ID: 15753459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of connexin 26 in human lung cancer is related to promoter methylation.
    Chen Y; Hühn D; Knösel T; Pacyna-Gengelbach M; Deutschmann N; Petersen I
    Int J Cancer; 2005 Jan; 113(1):14-21. PubMed ID: 15386363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
    Cowan LA; Talwar S; Yang AS
    Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition.
    Choi SH; Byun HM; Kwan JM; Issa JP; Yang AS
    Br J Haematol; 2007 Sep; 138(5):616-23. PubMed ID: 17686055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
    Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
    Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dna methylation by 5-aza-2'-deoxycytidine correlates with induction of K562 cells differentiation.
    Fabianowska-Majewska K; Wyczechowska D; Czyz M
    Adv Exp Med Biol; 2000; 486():343-7. PubMed ID: 11783512
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2'-deoxycytidine, in esophageal squamous cell carcinoma.
    Arai M; Imazeki F; Sakai Y; Mikata R; Tada M; Seki N; Shimada H; Ochiai T; Yokosuka O
    Oncol Rep; 2008 Aug; 20(2):405-12. PubMed ID: 18636205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo.
    Steele N; Finn P; Brown R; Plumb JA
    Br J Cancer; 2009 Mar; 100(5):758-63. PubMed ID: 19259094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
    Ando T; Nishimura M; Oka Y
    Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies.
    Orsini P; Impera L; Parciante E; Cumbo C; Minervini CF; Minervini A; Zagaria A; Anelli L; Coccaro N; Casieri P; Tota G; Brunetti C; Ricco A; Carluccio P; Specchia G; Albano F
    Diagn Pathol; 2018 Dec; 13(1):98. PubMed ID: 30579366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.
    Stresemann C; Lyko F
    Int J Cancer; 2008 Jul; 123(1):8-13. PubMed ID: 18425818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation and gene silencing in cancer.
    Baylin SB
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S4-11. PubMed ID: 16341240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors.
    Moreaux J; Rème T; Leonard W; Veyrune JL; Requirand G; Goldschmidt H; Hose D; Klein B
    Mol Cancer Ther; 2012 Dec; 11(12):2685-92. PubMed ID: 23087257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
    Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
    Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.